WHO authorizes new production site for Pfizer-BioNTech's Comirnaty vaccine


On 22 September 2021, WHO authorized a new site for production of Pfizer-BioNTech's Comirnaty vaccine, at Delpharm Saint-Remy's factory located at Rue de l'Isle, 28380 Saint-Remy-sur-Avre, France. There will now be six additional authorized sites for the final phase of production for this vaccine.  

Source: https://extranet.who.int/pqweb/vaccines/who-recommendation-covid-19-mrna-vaccine-nucleoside-modifiedcomirnaty

  • Share: